This infographic identifies key findings from the SOR 3 GPRA data in the first three-quarters of the grant, October 2022…
This infographic identifies key findings from the SOR 2 GPRA data from October 2020 through June 2023. DOWNLOAD THIS DOCUMENT
Please see the infographic below.
In light of the coronavirus pandemic, the Drug Enforcement Administration (DEA) has partnered with SAMHSA to ensure authorized practitioners may admit and treat new patients with opioid use disorder (OUD) during the public health emergency.
In response to the Novel Coronavirus Disease (COVID-19) pandemic, SAMHSA is providing updates to Frequently Asked Questions regarding the provision of methadone and buprenorphine for the treatment of Opioid Use Disorder for new and existing patients.
Tips for Community-based Syringe Services and Harm Reduction Providers DOWNLOAD THIS DOCUMENT
Harm Reduction during the COVID-19 Outbreak DOWNLOAD THIS DOCUMENT